Transgenic studies of alpha(1)-adrenergic receptor subtype function.

Area of Science:

• Pharmacology
• Cardiovascular Physiology
• Neuroscience

Background:

• Selective pharmacological agents for alpha(1)-adrenergic receptor (AR) subtypes are limited.
• Alpha(1)-ARs are key mediators of cardiovascular responses to agonists.
• Understanding subtype-specific functions is essential for physiological research.

Purpose of the Study:

• To elucidate the subtype-specific functions of alpha(1A)-, alpha(1B)-, and alpha(1D)-adrenergic receptor (AR) subtypes.
• To leverage genetically modified mouse models for functional studies.
• To advance the understanding of AR roles in cardiovascular and central nervous system regulation.

Main Methods:

• Generation of knockout (KO) and transgenic (TG) mice for specific alpha(1)-AR subtypes.
• Utilizing these genetically altered mouse models to study physiological responses.
• Comparing findings across different mouse strains with altered alpha(1)-AR genes.

Main Results:

• Alpha(1A)-AR and alpha(1B)-AR subtypes are critical for cardiac function and blood pressure regulation via vasoconstriction.
• Alpha(1B)-AR and alpha(1D)-AR subtypes are implicated in central nervous system functions, including pain perception and memory.
• Genetic manipulation in mice provides robust insights into subtype-specific AR functions.

Conclusions:

• Genetically engineered mouse models are indispensable tools for dissecting alpha(1)-AR subtype functions.
• These models have significantly enhanced our comprehension of AR roles in the cardiovascular system and CNS.
• Despite limitations, genetic approaches offer a powerful strategy for studying receptor biology.